What We're Reading: Page 137
Industry reads hand-picked by our editors
Oct 06, 2021
Oct 05, 2021
-
Associated Press
Henrietta Lacks estate sues company using her 'stolen' cells
-
ProPublica
McKinsey Never Told the FDA It Was Working for Opioid Makers While Also Working for the Agency
-
Reuters
A year after COVID vaccine waiver proposal, WTO talks are deadlocked
-
C&EN
Exo Therapeutics raises $78 million to target enzyme exosites with small molecules
Oct 04, 2021
-
Nature
Medicine Nobel goes to scientists who discovered biology of senses
-
The Wall Street Journal
Covid-19 Vaccine Makers Say There Are Enough Doses for Everyone. Poor Countries Are Still Waiting for Shots.
-
Axios
Pfizer loses case to subsidize heart drug for Medicare patients
-
STAT
Inside the downfall of longevity crusader Aubrey de Grey
Oct 01, 2021
-
The Wall Street Journal
Deaths Raise Safety Concerns Around Gene Therapy
-
Business Insider
A COVID-19 pill could soon fill a gap in our pandemic response that vaccines can’t overcome
-
Pink Sheet
Premature PRV: US FDA Mistakenly Announces Voucher Award For Enzyvant Ahead Of Approval
-
STAT
Mapping proteins could offer a clearer view of what’s driving cancer
Sep 30, 2021
Sep 29, 2021
-
The Boston Globe
Mass General Brigham won't offer Biogen’s new Alzheimer's drug
-
Bloomberg
I-Mab Said to Weigh Partnership, Stake Sale to Pharma Giants
-
The Wall Street Journal
India Aims to Produce mRNA Covid-19 Vaccine This Year
-
Reuters
U.S. FDA approves AbbVie's migraine prevention drug
Sep 28, 2021
-
The Wall Street Journal
Merck Nears Deal to Acquire Acceleron Pharma
-
The New York Times
Cancer Without Chemotherapy: 'A Totally Different World'
-
Endpoints News
The coronavirus vaccine that the world forgot could still help save it
-
C&EN
How the drug services industry found itself prepared for a pandemic
Previous
